Under the agreement, H. pylori medication Talicia will not require prior authorization and will have a $0 copay for Medi-Cal patients, according to an Oct. 1 press release.
Talicia has been listed by Medi-Cal since 2021, making it available to 15 million Californian patients.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
